Hedeker Wealth
ABBV icon

Hedeker Wealth’s AbbVie ABBV Stock Holding History

Hedeker Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$221K Buy
+845
New +$217K 0.04% 89
2025
Q4 		– Sell
-3,719
Closed -$861K – 88
2025
Q3 		$861K Buy
3,719
+50
+1% +$10.2K 0.18% 75
2025
Q2 		$681K Buy
3,669
+2,686
+273% +$499K 0.16% 76
2025
Q1 		$206K Buy
+983
New +$191K 0.06% 87
2023
Q3 		– Sell
-17,161
Closed -$2.31M – 85
2023
Q2 		$2.31M Sell
17,161
-414
-2% -$60.7K 0.77% 53
2023
Q1 		$2.8M Sell
17,575
-1,006
-5% -$154K 1% 48
2022
Q4 		$3M Buy
18,581
+50
+0.3% +$7.67K 1.12% 40
2022
Q3 		$2.49M Sell
18,531
-2,696
-13% -$387K 0.97% 46
2022
Q2 		$3.2M Buy
21,227
+2,130
+11% +$325K 1.1% 32
2022
Q1 		$3.1M Sell
19,097
-4,114
-18% -$598K 0.94% 45
2021
Q4 		$3.14M Sell
23,211
-3,033
-12% -$358K 0.91% 45
2021
Q3 		$2.83M Buy
26,244
+3,966
+18% +$453K 0.87% 44
2021
Q2 		$2.51M Buy
22,278
+1,036
+5% +$117K 0.78% 49
2021
Q1 		$2.3M Sell
21,242
-16
-0.1% -$1.71K 0.81% 47
2020
Q4 		$2.28M Sell
21,258
-730
-3% -$70.2K 0.8% 46
2020
Q3 		$1.92M Buy
21,988
+16,193
+279% +$1.52M 0.91% 49
2020
Q2 		$568K Buy
+5,795
New +$510K 0.29% 58
2016
Q4 		– Sell
-1,864
Closed -$29.6K – 117
2016
Q3 		$29.6K Sell
1,864
-27,469
-94% -$1.78M 1.53% 20
2016
Q2 		$1.82M Buy
29,333
+255
+0.9% +$15.5K 1.59% 15
2016
Q1 		$1.66M Buy
29,078
+276
+1% +$15.4K 1.56% 28
2015
Q4 		$1.71M Buy
28,802
+219
+0.8% +$12.6K 1.51% 25
2015
Q3 		$1.56M Buy
28,583
+191
+0.7% +$12.4K 1.35% 28
2015
Q2 		$1.91M Buy
28,392
+201
+0.7% +$13.1K 1.53% 26
2015
Q1 		$1.81M Buy
28,191
+215
+0.8% +$13K 1.5% 27
2014
Q4 		$1.83M Buy
+27,976
New +$1.76M 1.48% 29

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Hedeker Wealth's ABBV Position: Q3 2026 in Review

Hedeker Wealth opened a new position in AbbVie (ABBV) in Q3 2026: 845 shares worth $221K. The stake represents 0.04% of the portfolio and ranks #89 among its holdings. This is a return to the name: Hedeker Wealth previously reported a position in ABBV as recently as Q3 2025.

Hedeker Wealth first reported a position in ABBV in Q4 2014 and has held it in 25 quarters since. The position peaked at $3.2M in Q2 2022. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Hedeker Wealth held 845 shares of AbbVie worth $221K as of Q3 2026.
  • AbbVie was a new Hedeker Wealth position in Q3 2026.
  • AbbVie made up 0.04% of Hedeker Wealth's portfolio in Q3 2026, its #89 holding.
  • Hedeker Wealth first reported a position in AbbVie in Q4 2014 and has held it in 25 quarters since.
  • Hedeker Wealth's AbbVie position peaked at $3.2M in Q2 2022.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Hedeker Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.